Novabase S.G.P.S., S.A. (ELI:NBA)

SpringWorks Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	295	200	128	122	156	97
Market Cap Growth	53.11%	56.70%	5.02%	-22.10%	60.42%	24.95%
Enterprise Value	296	168	140	88	123	67
Last Close Price	8.10	5.11	3.62	2.95	3.42	2.15
PE Ratio	34.34	31.17	2.71	13.64	17.93	13.00
PS Ratio	2.27	1.49	0.96	1.01	1.13	0.78
PB Ratio	5.32	2.36	1.47	1.81	2.06	1.45
P/TBV Ratio	8.92	3.16	1.93	2.74	2.91	2.16
P/FCF Ratio	-	-	7.09	102.09	20.27	18.42
P/OCF Ratio	-	-	6.92	62.81	18.38	16.37
EV/Sales Ratio	2.28	1.25	1.06	0.73	0.88	0.53
EV/EBITDA Ratio	25.00	16.86	17.16	12.80	12.26	5.90
EV/EBIT Ratio	26.40	18.05	18.82	14.68	13.40	9.43
EV/FCF Ratio	-	-	7.79	73.51	15.92	12.62
Debt / Equity Ratio	0.31	0.24	0.32	0.20	0.29	0.46
Debt / EBITDA Ratio	1.47	1.56	2.55	1.42	1.76	2.13
Debt / FCF Ratio	-	-	1.54	11.13	2.86	5.86
Asset Turnover	0.87	0.79	0.81	0.76	0.83	0.69
Inventory Turnover	-	-	-	-	10107.77	3645.23
Quick Ratio	1.57	2.11	1.91	1.39	1.61	1.65
Current Ratio	1.58	2.20	2.03	1.49	1.70	1.74
Return on Equity (ROE)	13.04%	7.68%	4.44%	5.23%	12.47%	4.93%
Return on Assets (ROA)	4.69%	3.42%	2.86%	2.37%	3.41%	2.44%
Return on Capital (ROIC)	7.81%	5.27%	4.77%	4.18%	5.83%	4.09%
Return on Capital Employed (ROCE)	15.30%	8.60%	6.70%	7.80%	9.70%	7.20%
Earnings Yield	2.91%	3.21%	36.85%	7.33%	5.58%	7.69%
FCF Yield	-	-0.75%	14.11%	0.98%	4.93%	5.43%
Dividend Yield	16.67%	26.41%	49.40%	4.01%	-	-
Payout Ratio	-	721.28%	23.01%	-	-	-
Buyback Yield / Dilution	-	-17.36%	-4.55%	-0.26%	-0.79%	0.75%
Total Shareholder Return	16.67%	9.06%	44.85%	3.75%	-0.79%	0.75%

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.